AOD-9604 is a modified fragment of human growth hormone designed to target fat metabolism pathways without significantly affecting overall growth hormone levels.

In research settings it has been studied for lipolysis stimulation and fat-metabolism support.

• Add 2.0 mL bacteriostatic water → final concentration 2.5 mg/mL

• This concentration allows simple daily dosing.

• 250–500 mcg once daily

• Common research escalation:

250 mcg → 300 mcg → 500 mcg

• At 2.5 mg/mL → 1 unit = 0.01 mL ≈ 25 mcg on a U-100 insulin syringe.

Lyophilized

• Freeze at −20 °C

Reconstituted

• Refrigerate at 2–8 °C

• Use within 2–4 weeks

Frequency: Once daily, subcutaneous.

Draw 2.0 mL bacteriostatic water

Inject slowly down vial wall

Gently swirl — do not shake

Label reconstitution date

Refrigerate 2–8 °C

• 4 weeks: ~2–3 vials

• 12 weeks: ~6–8 vials

• 24 weeks: ~12–15 vials

• 1 per day

• 4 weeks: 28

• 12 weeks: 84

• 24 weeks: 168

• 2 mL per vial

Support fat metabolism signaling and lipid utilization.

• Once daily injections

• Escalation: 250 mcg → 300 mcg → 500 mcg

• Best taken fasted or before cardio

• Rotate injection sites

• Use sterile syringe each time

Disclaimer:

All peptide products sold on this website are for research, laboratory, and educational purposes only. They are not approved by the FDA or Health Canada, are not intended for human consumption, and should not be used for medical, cosmetic, or therapeutic purposes unless specifically prescribed by a licensed healthcare professional.

The information provided on this site is for informational and educational purposes only and does not constitute medical advice. Product descriptions, protocols, or references are not intended to diagnose, treat, cure, or prevent any disease. Always consult a qualified healthcare provider before beginning any new protocol, supplement, or treatment.

By purchasing from this website, you acknowledge and agree to use these products responsibly and in accordance with all applicable laws and guidelines.